Advertisement

Journal of Molecular Neuroscience

, Volume 68, Issue 1, pp 11–18 | Cite as

NF1 Somatic Mutation in Dystrophic Scoliosis

  • Rebecca L. Margraf
  • Chad VanSant-Webb
  • Rong Mao
  • David H. Viskochil
  • John Carey
  • Heather Hanson
  • Jacques D’Astous
  • Allie Grossmann
  • David A. StevensonEmail author
Article
  • 67 Downloads

Abstract

Scoliosis is a common manifestation of neurofibromatosis type 1, causing significant morbidity. The etiology of dystrophic scoliosis in neurofibromatosis type 1 is not fully understood and therapies are lacking. Somatic mutations in NF1 have been shown in tibial pseudarthrosis providing rationale for similar processes in neurofibromatosis type 1–associated dystrophic scoliosis. Spinal samples from surgical procedures with matched peripheral blood of two individuals with neurofibromatosis type 1 and dystrophic scoliosis were obtained and DNA extracted. Next generation sequencing of various spinal sections as well as the germline/blood sample were performed using a RASopathy gene panel (includes the NF1 gene). Variants were compared between the spinal tissue samples and the germline data. In addition, the next generation sequencing allele frequency data were used to detect somatic loss of heterozygosity. All samples had a detected potentially inactivating NF1 germline mutation. Both individuals demonstrated an allelic imbalance inclusive of NF1 in the next generation sequencing data. In addition, for the same two individuals, there was an increase in the % variant reads for the germline mutation in some of the surgical spinal samples corresponding to the allelic imbalance. Contra analysis did not show any deletion in Chromosome 17 next generation sequencing data. Microarray analysis verified somatic copy neutral loss of heterozygosity for these two individuals for the majority of the chromosome 17 q-arm, inclusive of the NF1 gene. These results suggest that the cause of dystrophic scoliosis is multifactorial and that a somatic NF1 mutation contributes to the etiology.

Keywords

Neurofibromatosis type 1 NF1 Scoliosis Somatic mutation Spine 

Notes

Acknowledgements

The authors thank the Shriners Hospital for Children (Salt Lake City, UT) and their clinicians and coordinators including Stephen Santora, Michael Pond, Janice Davis, Jeanne Siebert, Susan Geyer, Kyle Berg, and Austin Stevens for their role in consenting and collecting surgical tissues and for their input.

Funding Information

This work was supported by grants from the Department of Defense (award W81XWH-11-1-250; David Stevenson, David Viskochil, and John Carey), and Shriners Hospital for Children (no. 9198; Jacques D’Astous, David Stevenson, John Carey, and David Viskochil). Portions of the research were supported by the University of Utah Clinical Genetics Research Program (David Viskochil) and the National Center for Research Resources and National Center for Advancing Translational Sciences at the National Institutes of Health (UL1RR025764).

References

  1. Akbarnia BA, Gabriel KR, Beckman E, Chalk D (1992) Prevalence of scoliosis in neurofibromatosis. Spine 17:S244–S248CrossRefGoogle Scholar
  2. Crawford AH (1989) Pitfalls of spinal deformities associated with neurofibromatosis in children. Clin Orthop Relat Res(245):29-42Google Scholar
  3. Crawford AH Jr, Bagamery N (1986) Osseous manifestations of neurofibromatosis in childhood. J Pediatr Orthop 6:72–88CrossRefGoogle Scholar
  4. Crawford AH, Schorry EK (1999) Neurofibromatosis in children: the role of the orthopaedist. J Am Acad Orthop Surg 7:217–230CrossRefGoogle Scholar
  5. de la Croix Ndong J, Makowski AJ, Uppuganti S, Vignaux G, Ono K, Perrien DS, Joubert S, Baglio SR, Granchi D, Stevenson DA, Rios JJ, Nyman JS, Elefteriou F (2014) Asfotase-alpha improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1. Nat Med 20:904–910.  https://doi.org/10.1038/nm.3583 CrossRefGoogle Scholar
  6. Durrani AA, Crawford AH, Chouhdry SN, Saifuddin A, Morley TR (2000) Modulation of spinal deformities in patients with neurofibromatosis type 1. Spine 25:69–75CrossRefGoogle Scholar
  7. Funasaki H, Winter RB, Lonstein JB, Denis F (1994) Pathophysiology of spinal deformities in neurofibromatosis. An analysis of seventy-one patients who had curves associated with dystrophic changes. J Bone Joint Surg Am 76:692–700CrossRefGoogle Scholar
  8. Li J, Lupat R, Amarasinghe KC, Thompson ER, Doyle MA, Ryland GL, Tothill RW, Halgamuge SK, Campbell IG, Gorringe KL (2012) CONTRA: copy number analysis for targeted resequencing. Bioinformatics 28:1307–1313.  https://doi.org/10.1093/bioinformatics/bts146 CrossRefGoogle Scholar
  9. Margraf RL, VanSant-Webb C, Sant D, Carey J, Hanson H, D'Astous J, Viskochil D, Stevenson DA, Mao R (2017) Utilization of whole-exome next-generation sequencing variant read frequency for detection of lesion-specific, somatic loss of heterozygosity in a neurofibromatosis type 1 cohort with tibial pseudarthrosis. J Mol Diagn 19:468–474.  https://doi.org/10.1016/j.jmoldx.2017.01.008 CrossRefGoogle Scholar
  10. Paria N, Cho TJ, Choi IH, Kamiya N, Kayembe K, Mao R, Margraf RL, Obermosser G, Oxendine I, Sant DW, Song MH, Stevenson DA, Viskochil DH, Wise CA, Kim HKW, Rios JJ (2014) Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1. J Bone Miner Res 29:2636–2642.  https://doi.org/10.1002/jbmr.2298 CrossRefGoogle Scholar
  11. Rhodes SD, Zhang W, Yang D, Yang H, Chen S, Wu X, Li X, Yang X, Mohammad KS, Guise TA, Bergner AL, Stevenson DA, Yang FC (2015) Dystrophic spinal deformities in a neurofibromatosis type 1 murine model. PLoS One 10:e0119093.  https://doi.org/10.1371/journal.pone.0119093 CrossRefGoogle Scholar
  12. Sant DW, Margraf RL, Stevenson DA, Grossmann AH, Viskochil DH, Hanson H, Everitt MD, Rios JJ, Elefteriou F, Hennessey T, Mao R (2015) Evaluation of somatic mutations in tibial pseudarthrosis samples in neurofibromatosis type 1. J Med Genet 52:256–261.  https://doi.org/10.1136/jmedgenet-2014-102815 CrossRefGoogle Scholar
  13. Stevenson DA, Zhou H, Ashrafi S, Messiaen LM, Carey JC, D’Astous JL, Santora SD, Viskochil DH (2006) Double inactivation of NF1 in tibial pseudarthrosis. Am J Hum Genet 79:143–148.  https://doi.org/10.1086/504441 CrossRefGoogle Scholar
  14. Wang W, Nyman JS, Ono K, Stevenson DA, Yang X, Elefteriou F (2011) Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I. Hum Mol Genet 20:3910–3924.  https://doi.org/10.1093/hmg/ddr310 CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Rebecca L. Margraf
    • 1
  • Chad VanSant-Webb
    • 1
  • Rong Mao
    • 1
    • 2
  • David H. Viskochil
    • 3
    • 4
  • John Carey
    • 3
    • 4
  • Heather Hanson
    • 3
  • Jacques D’Astous
    • 4
  • Allie Grossmann
    • 2
  • David A. Stevenson
    • 5
    Email author
  1. 1.ARUP Institute for Clinical and Experimental PathologyARUP LaboratoriesSalt Lake CityUSA
  2. 2.Department of Pathology, School of MedicineUniversity of UtahSalt Lake CityUSA
  3. 3.Department of Pediatrics, Division of Medical Genetics, School of MedicineUniversity of UtahSalt Lake CityUSA
  4. 4.Shriners Hospital for ChildrenSalt Lake CityUSA
  5. 5.Department of Pediatrics, Division of Medical GeneticsStanford UniversityStanfordUSA

Personalised recommendations